Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-19

Clinical Trial Update: Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis

View source ↗

Summary

This completed clinical trial explored whether urine cadmium levels can predict the risk of pancreatic cancer in people with chronic pancreatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pancreatic Cancer, Precancerous Condition | Status: COMPLETED